151 related articles for article (PubMed ID: 35924957)
1. Social determinants of health and cardiovascular outcomes in patients with heart failure.
Vinter N; Fawzy AM; Gent D; Ding WY; Johnsen SP; Frost L; Trinquart L; Lip GYH
Eur J Clin Invest; 2022 Nov; 52(11):e13843. PubMed ID: 35924957
[TBL] [Abstract][Full Text] [Related]
2. Vascular Disease and Risk Stratification for Ischemic Stroke and All-Cause Death in Heart Failure Patients without Diagnosed Atrial Fibrillation: A Nationwide Cohort Study.
Melgaard L; Gorst-Rasmussen A; Rasmussen LH; Lip GY; Larsen TB
PLoS One; 2016; 11(3):e0152269. PubMed ID: 27015524
[TBL] [Abstract][Full Text] [Related]
3. Social determinants of health and catheter ablation after an incident diagnosis of atrial fibrillation: a Danish nationwide cohort study.
Vinter N; Calvert P; Kronborg MB; Cosedis-Nielsen J; Gupta D; Ding WY; Trinquart L; Johnsen SP; Frost L; Lip GYH
Eur Heart J Qual Care Clin Outcomes; 2023 Jun; 9(4):389-396. PubMed ID: 35810004
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study.
Bansal N; Xie D; Sha D; Appel LJ; Deo R; Feldman HI; He J; Jamerson K; Kusek JW; Messe S; Navaneethan SD; Rahman M; Ricardo AC; Soliman EZ; Townsend R; Go AS
J Am Soc Nephrol; 2018 Dec; 29(12):2859-2869. PubMed ID: 30377231
[TBL] [Abstract][Full Text] [Related]
5. Relation of Serum Uric Acid and Cardiovascular Events in Young Adults Aged 20-49 Years.
Seki H; Kaneko H; Morita H; Itoh H; Morita K; Matsuoka S; Kiriyama H; Kamon T; Fujiu K; Michihata N; Jo T; Takeda N; Yano Y; Nakamura S; Node K; Yasunaga H; Komuro I
Am J Cardiol; 2021 Aug; 152():150-157. PubMed ID: 34140140
[TBL] [Abstract][Full Text] [Related]
6. Association between remnant cholesterol and incident atherosclerotic cardiovascular disease, heart failure, and atrial fibrillation.
Tada H; Kaneko H; Suzuki Y; Okada A; Takeda N; Fujiu K; Morita H; Ako J; Node K; Takeji Y; Takamura M; Yasunaga H; Komuro I
J Clin Lipidol; 2024; 18(1):3-10. PubMed ID: 38061922
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
[TBL] [Abstract][Full Text] [Related]
8. Plasma TSH and cardiovascular disease in the general population: A Mendelian randomization study of 105,224 individuals.
Dalila N; Frikke-Schmidt R; Nordestgaard BG; Tybjærg-Hansen A
Atherosclerosis; 2023 Jul; 376():26-33. PubMed ID: 37263031
[TBL] [Abstract][Full Text] [Related]
9. Circulating Magnesium and Risk of Major Adverse Cardiac Events among Patients with Atrial Fibrillation in the ARIC Cohort.
Li L; Lutsey PL; Chen LY; Soliman EZ; Rooney MR; Alonso A
Nutrients; 2023 Feb; 15(5):. PubMed ID: 36904210
[No Abstract] [Full Text] [Related]
10. Social determinants of health and recurrence of atrial fibrillation after catheter ablation: a Danish nationwide cohort study.
Vinter N; Calvert P; Kronborg MB; Cosedis-Nielsen J; Gupta D; Ding WY; Trinquart L; Johnsen SP; Frost L; Lip GYH
Eur Heart J Qual Care Clin Outcomes; 2023 Sep; 9(6):632-638. PubMed ID: 36302141
[TBL] [Abstract][Full Text] [Related]
11. Characteristics, treatment, and outcomes of newly diagnosed atrial fibrillation patients with heart failure: GARFIELD-AF.
Ambrosio G; Camm AJ; Bassand JP; Corbalan R; Kayani G; Carluccio E; Mantovani LG; Virdone S; Kakkar AK;
ESC Heart Fail; 2021 Apr; 8(2):1139-1149. PubMed ID: 33434417
[TBL] [Abstract][Full Text] [Related]
12. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
Cherian TS; Shrader P; Fonarow GC; Allen LA; Piccini JP; Peterson ED; Thomas L; Kowey PR; Gersh BJ; Mahaffey KW
Am J Cardiol; 2017 Jun; 119(11):1763-1769. PubMed ID: 28416199
[TBL] [Abstract][Full Text] [Related]
13. Digoxin use and outcomes after myocardial infarction in patients with atrial fibrillation.
Kytö V; Saraste A; Rautava P; Tornio A
Basic Clin Pharmacol Toxicol; 2022 Jun; 130(6):655-665. PubMed ID: 35420260
[TBL] [Abstract][Full Text] [Related]
14. Stroke-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications Following Stroke.
Buckley BJR; Harrison SL; Hill A; Underhill P; Lane DA; Lip GYH
Stroke; 2022 May; 53(5):1759-1763. PubMed ID: 35354300
[TBL] [Abstract][Full Text] [Related]
15. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
[TBL] [Abstract][Full Text] [Related]
16. Association between exercise habits and stroke, heart failure, and mortality in Korean patients with incident atrial fibrillation: A nationwide population-based cohort study.
Ahn HJ; Lee SR; Choi EK; Han KD; Jung JH; Lim JH; Yun JP; Kwon S; Oh S; Lip GYH
PLoS Med; 2021 Jun; 18(6):e1003659. PubMed ID: 34101730
[TBL] [Abstract][Full Text] [Related]
17. Tooth Loss Predicts Myocardial Infarction, Heart Failure, Stroke, and Death.
Lee HJ; Choi EK; Park JB; Han KD; Oh S
J Dent Res; 2019 Feb; 98(2):164-170. PubMed ID: 30782090
[TBL] [Abstract][Full Text] [Related]
18. The Cumulative Incidence of Stroke, Myocardial infarction, Heart Failure and Sudden Cardiac Death in Patients with Atrial Fibrillation.
Naser N; Kulic M; Dilic M; Dzubur A; Durak A; Pepic E; Smajic E; Kusljugic Z
Med Arch; 2017 Oct; 71(5):316-319. PubMed ID: 29284897
[TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation is associated with an increased risk of myocardial infarction: Insights from a meta-analysis.
Guo XY; Li N; Du X; Bai R; Yu RH; Long DY; Tang RB; Sang CH; Jiang CX; Ning M; Li SN; Liu N; Dong JZ; Ma CS
Atherosclerosis; 2016 Nov; 254():1-7. PubMed ID: 27673698
[TBL] [Abstract][Full Text] [Related]
20. Long-term risk of adverse outcomes according to atrial fibrillation type.
Blum S; Aeschbacher S; Coslovsky M; Meyre PB; Reddiess P; Ammann P; Erne P; Moschovitis G; Di Valentino M; Shah D; Schläpfer J; Müller R; Beer JH; Kobza R; Bonati LH; Moutzouri E; Rodondi N; Meyer-Zürn C; Kühne M; Sticherling C; Osswald S; Conen D;
Sci Rep; 2022 Feb; 12(1):2208. PubMed ID: 35140237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
